Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sunday share tips: Futura Medical, Serco

Sun 16 Jul 2023 12:33

(Sharecast News) - The Sunday Times's Lucy Tobin told readers that shares of Futura Medical were worth a punt, even if there were no guarantees of a happy ending.

Although the company had just 14 staff and directors, it had a new product that worked, Eroxon, a gel for those suffering from erectile dysfunction, which did not require a prescription in order to be sold.

Given that the market for ED was expected to surpass $6bn in value by 2032, the business's future looked appealing.

And unlike rival products Viagra and Cialis, both of which required a prescription, Eroxon took just 10 minutes to work, not half an hour.

The company was expecting approval for Eroxon in Saudi Arabia in September and was working on having a US partner for commercialisation which would likely a surge in the share price.

"There are no guarantees of a happy ending, but it's a worthy punt. Buy."

The Financial Mail on Sunday's told readers to 'buy' shares of Serco, although it conceded that risks were not absent.

The outsourcer was well-placed to benefit form government outlays on immigration and defence in many regions of the world, the tipster argued.

On the flip-side, there were multiple potential risks.

For starters, making up the loss of Covid-related work "wasn't always easy".

Furthermore, the possibility existed that it might lose the Australian immigration contract that was up for renewal in 2023.

Serco also had a tendency to work in "high-profile" and "controversial" areas, including on immigration which in the past had led to scandal and had an extremely negative impact on its share prices.

"There's no suggestion that the current management is likely to lead the company into any problems like this though, since former chief executive Rupert Soames is credited with shaking out any problems at the business, leaving it in stronger shape.

"At 156p, the shares are a buy."

Share this article

Related Sharecast Articles

Wed 28 Oct 2026 07:16
Wednesday newspaper round-up: Sizewell plant, Rosebank oilfield, Google
(Sharecast News) - The government's plan to fund a multibillion-pound nuclear plant at the Sizewell site in Suffolk represents a "terrible deal" for the UK taxpayer over the rest of the century, according to the government's spending watchdog. MPs on the public accounts committee (PAC) have warned the government that the cost of the Sizewell C nuclear reactor could spiral to almost £48bn, leaving bill payers on the hook to provide an extra £9.8bn to construct the plant before 2040 and a further £12bn over its 60-year operating life. - Guardian
Tue 27 Oct 2026 07:12
Tuesday newspaper round-up: Shop price inflation, Microsoft, Helsing
(Sharecast News) - Shop price inflation has risen to the highest level in two and a half years, according to the British Retail Consortium, which warned that "the dam is starting to break" when it comes to retailers trying to limit price rises for customers. The lobby group said shop price inflation was 2.1% year on year in October, a sharp rise compared with 1.4% in September, and an indication that retailers were beginning to pass on the rising costs of energy and food ingredients since the Middle East conflict broke out. - Guardian
Mon 26 Oct 2026 07:23
Monday newspaper round-up: Pensioners and the Budget, interest rate expectations, Audi US factory
(Sharecast News) - The chancellor will use his Budget this week to protect pensioners and those saving for their retirement, as he announces plans to shield nearly 1m people from paying income tax. John Healey is expected to confirm on Wednesday that the full state pension will rise by £489 to £13,036 - equivalent to 3.9%. However, the rise will push about 1m people on low incomes who rely on the state pension above the £12, 570 personal allowance threshold, meaning they would be dragged into paying income tax. To retain the principle that the state pension is not taxable, Healey is expected to announce a rise in the tax-free allowance for low-income pensions to £13,036. The move will cost taxpayers £200m a year by 20230 - The Times
Fri 23 Oct 2026 07:20
Friday newspaper round-up: Elon Musk/Skydance, North Sea wealth fund, retiring entrepreneurs
(Sharecast News) - Elon Musk has reportedly invested approximately $1bn in Skydance, the new media empire led by David Ellison. The deal comes alongside fresh equity infusions from existing investors, including board member Laurene Powell Jobs, Steve Jobs's widow. Semafor first reported the news. The investment follows Paramount's recent $111bn merger with Warner Bros Discovery, a huge acquisition that brought the media companies together under the Skydance name. At the head of the new media empire is David Ellison, the son of billionaire Oracle co-founder and Donald Trump ally Larry Ellison. - Guardian

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Awards

Award 1
Award 2
Award 3

Policies and important information

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statements | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Statutory and Regulatory disclosures | Whistleblowing programme

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026